Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09
Published September 24, 2025 · Recall initiated: July 8, 2025
Summary
FDA records medical device Class II recall Z-2558-2025, published September 24, 2025 and initiated July 8, 2025. Recalling firm: Boston Scientific Neuromodulation Corporation; Status: Ongoing; Reported quantity: 25,260; Lot: UDI-DI: 08714729985044, 08714729985051. Document Number/Revision: 92328632-09, Rev A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Wire break(s) have occurred in rechargeable deep brain stimulation implantable pulse generators, implanted in the submuscular pectoral location. Wire breaks prevent successful stimulation, thus requiring device removal/replacement and users may experience high monopolar impedances, undesired sensation, loss of therapy, return of symptoms and/or Bluetooth connectivity challenges.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Boston Scientific Neuromodulation Corporation
- Distributor
- Worldwide - US Nationwide distribution including in the states of MN, FL, CO, MD, NY, NE, PA, WI, AZ, TN, MO, TX, MI, MT, MA, WV, AL, VA, NC, CA, OR, WA, LA, OH, NJ, NH, SD, GA, CT, NV, UT, IN, ID, IL, ME, SC, DC, OK, KY, AK, HI, RI, AR, KS, NM and the countries of Argentina, Brazil, Chile, Ecuador, Colombia , Mexico, Canada, Japan, Algeria, Austria, Azerbaijan, Belgium, Bulgaria, Croatia, Denmark, Egypt, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Iran, Ireland, Israel, Italy, Jordan, Kazakhstan, Kuwait, Lebanon, Libya, Luxembourg, Malta, Morocco, Netherlands, Norway, Pakistan, Poland, Portugal, Romania, Russian Fed., Saudi Arabia, Serbia, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkiye, UAE, Ukraine, United Kingdom, Hong Kong, China, Singapore, Korea, Taiwan , India, Thailand.
- Lot
- UDI-DI: 08714729985044, 08714729985051. Document Number/Revision: 92328632-09, Rev A
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDANalu TD2 Therapy Disc with firmware, REF: 34014-001, and TD2 Patient Kit, REF: 74011, part of the NaluNovember 4, 2026
- FDAINFINION CX LEAD KIT, 50CM, Model: SC-2317-50, Material: M365SC2317500; INFINION CX LEAD KIT, 70CM, Model:August 12, 2026
- FDAIntracept Access Instruments, Description/REF: INTRACEPT ACCESS INSTRUMENTS- DRILL/RLV0035, INTRACEPT ACCESSJuly 15, 2026
- FDABoston Scientific Model SC-4318, Clik X Anchor REF: M365SC43180June 17, 2026
- FDAMax Mobility/Permobil Smart Drive MX2+ SpeedControl Dial Ref: MX2-3DCMC use in conjunction with the SmartDriveSeptember 24, 2025
- FDAExactech Equinoxe, Reverse Shoulder Humeral Liners, 322-38-00 (145-DEG PE 38MM HUM LINER +0), REF: 322-38-03September 24, 2025
Questions about this recall
Was Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09 recalled?
Yes. FDA published recall Z-2558-2025 on September 24, 2025. Reported hazard: Wire break(s) have occurred in rechargeable deep brain stimulation implantable pulse generators, implanted in the submuscular pectoral location. Wire breaks prevent successful stimulation, thus requiring device removal/replacement and users may experience high monopolar impedances, undesired sensation, loss of therapy, return of symptoms and/or Bluetooth connectivity challenges.
What should I do if I have this product?
Voluntary: Firm initiated · Letter